Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Arcus Biosciences Debt to Equity Ratio 2017-2019 | RCUS

Current and historical debt to equity ratio values for Arcus Biosciences (RCUS) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Arcus Biosciences debt/equity for the three months ending December 31, 2019 was 0.00.
  
Arcus Biosciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-12-31 $0.00B $0.16B 0.00
2019-09-30 $0.00B $0.18B 0.00
2019-06-30 $0.00B $0.20B 0.00
2019-03-31 $0.00B $0.22B 0.00
2018-12-31 $0.00B $0.24B 0.00
2018-09-30 $0.00B $0.25B 0.00
2018-06-30 $0.00B $0.26B 0.00
2018-03-31 $0.00B $0.27B 0.00
2017-12-31 $0.00B $-0.07B 0.00
2017-09-30 $0.00B 0.00
2017-06-30 $0.00B 0.00
2017-03-31 $0.00B 0.00
2016-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.582B $0.015B
Arcus Biosciences is a biopharmaceutical company. It focused on creating innovative cancer immunotherapies. The company's product portfolio includes AB928, AB122, AB154 and AB680. AB928 which is in its final phase is a potent and selective dual antagonist of the adenosine receptors. AB122 which is in its Phase1 is a monoclonal antibody which potently and selectively blocks a protein called PD-1. AB154 is a monoclonal antibody which potently and selectively blocks a novel immune checkpoint called TIGIT. AB680, which is in its Phase1 is a potent and selective inhibitor of CD73, the enzyme responsible for the extracellular production of adenosine within the tumor micro-environment. Arcus Biosciences is based in Hayward, CA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.941B 13.37
Gilead Sciences (GILD) United States $91.719B 11.86
CSL (CSLLY) Australia $79.295B 0.00
Vertex Pharmaceuticals (VRTX) United States $56.324B 51.12
Biogen (BIIB) United States $51.654B 8.82
Regeneron Pharmaceuticals (REGN) United States $49.455B 20.95
Illumina (ILMN) United States $39.550B 40.89
Seattle Genetics (SGEN) United States $18.823B 0.00
Alexion Pharmaceuticals (ALXN) United States $18.600B 8.65
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.120B 0.00
Incyte (INCY) United States $14.949B 32.07
BioMarin Pharmaceutical (BMRN) United States $14.306B 611.61
Genmab (GNMSF) Denmark $12.862B 41.37
BioNTech SE (BNTX) Germany $12.444B 0.00
Alnylam Pharmaceuticals (ALNY) United States $11.782B 0.00
Galapagos (GLPG) Belgium $11.779B 25.73
Bio-Rad Laboratories (BIO.B) United States $9.935B 46.43
Moderna (MRNA) United States $9.887B 0.00
QIAGEN (QGEN) Netherlands $9.213B 28.09
Exact Sciences (EXAS) United States $8.567B 0.00
BeiGene (BGNE) Cayman Islands $8.176B 0.00
Sarepta Therapeutics (SRPT) United States $7.345B 0.00
Bio-Techne Corp (TECH) United States $7.072B 48.40
Guardant Health (GH) United States $6.398B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.032B 0.00
Ascendis Pharma (ASND) Denmark $5.414B 0.00
Exelixis (EXEL) United States $5.262B 16.89
Horizon Therapeutics Public (HZNP) Ireland $5.235B 13.83
Reata Pharmaceuticals (RETA) United States $4.984B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.980B 0.00
Repligen (RGEN) United States $4.820B 88.14
Amarin (AMRN) Ireland $4.730B 0.00
Acceleron Pharma (XLRN) United States $4.643B 0.00
China Biologic Products (CBPO) China $4.279B 25.40
Vir Biotechnology (VIR) United States $3.762B 0.00
MorphoSys AG (MOR) Germany $3.364B 0.00
Mirati Therapeutics (MRTX) United States $3.318B 0.00
Adaptive Biotechnologies (ADPT) United States $3.206B 0.00
Blueprint Medicines (BPMC) United States $3.140B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.130B 0.00
Global Blood Therapeutics (GBT) United States $3.110B 0.00
Zai Lab (ZLAB) China $2.961B 0.00
Immunomedics (IMMU) United States $2.747B 0.00
NeoGenomics (NEO) United States $2.695B 116.86
Emergent Biosolutions (EBS) United States $2.663B 18.49
Bluebird Bio (BLUE) United States $2.657B 0.00
Genmab (GMAB) Denmark $2.588B 10.15
CRISPR Therapeutics AG (CRSP) Switzerland $2.545B 43.11
MyoKardia (MYOK) United States $2.488B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.452B 0.00
Halozyme Therapeutics (HALO) United States $2.416B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.329B 0.00
Amicus Therapeutics (FOLD) United States $2.300B 0.00
Alkermes (ALKS) Ireland $2.272B 180.00
Arena Pharmaceuticals (ARNA) United States $2.238B 5.83
RA PHARMCTL INC (RARX) United States $2.220B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.138B 0.00
Denali Therapeutics (DNLI) United States $1.995B 0.00
UniQure (QURE) Netherlands $1.959B 0.00
Epizyme (EPZM) United States $1.792B 0.00
Alector (ALEC) United States $1.787B 0.00
Viela Bio (VIE) United States $1.769B 0.00
Fate Therapeutics (FATE) United States $1.684B 0.00
Principia Biopharma (PRNB) United States $1.673B 0.00
Eidos Therapeutics (EIDX) United States $1.618B 0.00
Insmed (INSM) United States $1.541B 0.00
Arvinas (ARVN) United States $1.538B 0.00
Zymeworks (ZYME) Canada $1.470B 0.00
Akcea Therapeutics (AKCA) United States $1.345B 28.93
Dicerna Pharmaceuticals (DRNA) United States $1.263B 0.00
REGENXBIO (RGNX) United States $1.258B 0.00
Inovio Pharmaceuticals (INO) United States $1.213B 0.00
Coherus BioSciences (CHRS) United States $1.148B 13.66
Ligand Pharmaceuticals (LGND) United States $1.102B 34.25
Editas Medicine (EDIT) United States $1.095B 0.00
Twist Bioscience (TWST) United States $1.063B 0.00
Zealand Pharma (ZEAL) Denmark $1.054B 0.00
Myriad Genetics (MYGN) United States $1.048B 18.50
NextCure (NXTC) United States $1.007B 0.00
PHARMA MAR SA (PHMMF) Spain $0.983B 0.00
Adverum Biotechnologies (ADVM) United States $0.911B 0.00
Revance Therapeutics (RVNC) United States $0.887B 0.00
NGM Biopharmaceuticals (NGM) United States $0.886B 0.00
Zealand Pharma (ZLDPF) Denmark $0.881B 0.00
Intra-Cellular Therapies (ITCI) United States $0.877B 0.00
Sangamo Therapeutics (SGMO) United States $0.737B 0.00
Cytokineticsorporated (CYTK) United States $0.699B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.680B 0.00
Novavax (NVAX) United States $0.672B 0.00
Kadmon Holdings (KDMN) United States $0.637B 0.00
Athenex (ATNX) United States $0.615B 0.00
Pharming Group (PHGUF) Netherlands $0.613B 0.00
Frequency Therapeutics (FREQ) United States $0.609B 0.00
Codexis (CDXS) United States $0.607B 0.00
Retrophin (RTRX) United States $0.594B 0.00
Cara Therapeutics (CARA) United States $0.589B 0.00
Intellia Therapeutics (NTLA) United States $0.583B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.582B 0.00
Bellus Health (BLU) Canada $0.554B 0.00
GENFIT S.A (GNFT) France $0.552B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.537B 0.00
Intrexon (PGEN) United States $0.533B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.528B 0.00
Clovis Oncology (CLVS) United States $0.524B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.491B 4.32
Compugen (CGEN) Israel $0.491B 0.00
Castle Biosciences (CSTL) United States $0.486B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
ANI Pharmaceuticals (ANIP) United States $0.457B 8.24
Mesoblast (MESO) Australia $0.435B 0.00
DBV Technologies S.A (DBVT) France $0.434B 0.00
MeiraGTx Holdings (MGTX) United States $0.429B 0.00
AC Immune SA (ACIU) Switzerland $0.429B 9.92
Morphic Holding (MORF) United States $0.427B 0.00
Vericel (VCEL) United States $0.422B 62.60
Heska (HSKA) United States $0.419B 0.00
Anika Therapeutics (ANIK) United States $0.415B 14.29
Aquinox Pharmaceuticals (NLTX) United States $0.405B 0.00
MiMedx (MDXG) United States $0.403B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.400B 0.00
Scholar Rock Holding (SRRK) United States $0.400B 0.00
Verastem (VSTM) United States $0.400B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.398B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.385B 0.00
Prothena (PRTA) Ireland $0.383B 0.00
AnaptysBio (ANAB) United States $0.382B 0.00
Agenus (AGEN) United States $0.380B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.371B 0.00
UROGEN PHARMA (URGN) United States $0.370B 0.00
Cellectis S.A (CLLS) France $0.365B 0.00
Merus (MRUS) Netherlands $0.360B 0.00
Cue Biopharma (CUE) United States $0.352B 0.00
BioDelivery Sciences (BDSI) United States $0.340B 39.22
Puma Biotechnology (PBYI) United States $0.338B 0.00
PDL BioPharma (PDLI) United States $0.336B 10.07
Sorrento Therapeutics (SRNE) United States $0.328B 0.00
Athersys (ATHX) United States $0.322B 0.00
WAVE Life Sciences (WVE) Singapore $0.319B 0.00
Precision BioSciences (DTIL) United States $0.318B 0.00
NantKwest (NK) United States $0.310B 0.00
Dynavax Technologies (DVAX) United States $0.307B 0.00
Cellular Biomedicine (CBMG) United States $0.297B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.292B 0.00
CytomX Therapeutics (CTMX) United States $0.289B 0.00
Mersana Therapeutics (MRSN) United States $0.287B 0.00
Kala Pharmaceuticals (KALA) United States $0.285B 0.00
ADMA Biologics Inc (ADMA) United States $0.265B 0.00
Avid Bioservices (CDMO) United States $0.264B 0.00
Albireo Pharma (ALBO) United States $0.248B 0.00
Kamada (KMDA) Israel $0.244B 10.17
Seres Therapeutics (MCRB) United States $0.244B 0.00
Alcobra (ARCT) United States $0.239B 0.00
Sutro Biopharma (STRO) United States $0.226B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.226B 0.00
MannKind (MNKD) United States $0.225B 0.00
Stemline Therapeutics (STML) United States $0.222B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.218B 0.00
Syros Pharmaceuticals (SYRS) United States $0.218B 0.00
Geron (GERN) United States $0.214B 0.00
Aduro Biotech (ADRO) United States $0.206B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.204B 0.00
Gritstone Oncology (GRTS) United States $0.202B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.193B 1.73
XOMA (XOMA) United States $0.185B 0.00
Selecta Biosciences (SELB) United States $0.183B 0.00
ChromaDex (CDXC) United States $0.176B 0.00
OSMOTICA PHARM (OSMT) United States $0.176B 0.00
Protagonist Therapeutics (PTGX) United States $0.175B 0.00
HOOKIPA Pharma (HOOK) United States $0.173B 0.00
IVERIC Bio (ISEE) United States $0.172B 0.00
Abeona Therapeutics (ABEO) United States $0.172B 0.00
Starpharma Holdings (SPHRY) Australia $0.168B 0.00
VBI Vaccines (VBIV) United States $0.166B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Prometic Life Sciences (LMNL) Canada $0.160B 0.00
Kindred Biosciences (KIN) United States $0.160B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.158B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.152B 0.00
POXEL SA FRANCE (PXXLF) France $0.145B 0.00
Windtree Therapeutics (WINT) United States $0.144B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.137B 0.00
Cerecor (CERC) United States $0.136B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.135B 0.00
Fortress Biotech (FBIO) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.132B 0.00
VTv Therapeutics (VTVT) United States $0.132B 0.00
Dyadic (DYAI) United States $0.122B 0.00
Antibe Therapeutics (ATBPF) Canada $0.121B 0.00
Affimed (AFMD) Germany $0.119B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.118B 0.00
Theratechnologies (THTX) Canada $0.118B 0.00
Enzo Biochem (ENZ) United States $0.117B 0.00
Exicure (XCUR) United States $0.115B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.110B 0.00
AIT Therapeutics (XAIR) United States $0.104B 0.00
Northwest Biotherapeutics (NWBO) United States $0.102B 0.00
Strongbridge Biopharma (SBBP) United States $0.101B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.096B 0.00
Aptinyx (APTX) United States $0.095B 0.00
TELA Bio (TELA) United States $0.091B 0.00
OvaScience (MLND) United States $0.088B 0.00
Checkpoint Therapeutics (CKPT) United States $0.086B 0.00
ARAVIVE, INC (ARAV) United States $0.086B 0.00
Five Prime Therapeutics (FPRX) United States $0.085B 0.00
Cyclerion Therapeutics (CYCN) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.083B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Eton Pharmaceuticals (ETON) United States $0.078B 0.00
Happiness Biotech Group (HAPP) China $0.075B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
Menlo Therapeutics (MNLO) United States $0.070B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.067B 0.00
Vaccinex (VCNX) United States $0.066B 0.00
Adocia (ADOCY) France $0.066B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
SESEN BIO, INC (SESN) United States $0.062B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
Orgenesis (ORGS) United States $0.061B 3.55
Synlogic (SYBX) United States $0.060B 0.00
AquaBounty Technologies (AQB) United States $0.059B 0.00
Catalyst Biosciences (CBIO) United States $0.057B 0.00
Trevena (TRVN) United States $0.056B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.052B 0.00
Acorda Therapeutics (ACOR) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.047B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.047B 0.00
Idera Pharmaceuticals (IDRA) United States $0.043B 0.00
Organovo Holdings (ONVO) United States $0.038B 0.00
Soligenix (SNGX) United States $0.038B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.036B 0.00
Lumos Pharma (LUMO) United States $0.036B 0.00
Advaxis (ADXS) United States $0.034B 0.00
DiaMedica Therapeutics (DMAC) United States $0.034B 0.00
CollPlant Holdings (CLGN) Israel $0.034B 0.00
TOCAGEN INC (TOCA) United States $0.031B 0.00
Celldex Therapeutics (CLDX) United States $0.030B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.028B 0.00
Prima BioMed (IMMP) Australia $0.028B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Entera Bio (ENTX) Israel $0.027B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Curis (CRIS) United States $0.026B 0.00
VistaGen Therapeutics (VTGN) United States $0.023B 0.00
Pulmatrix (PULM) United States $0.023B 0.00
Alimera Sciences (ALIM) United States $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Novogen (KZIA) Australia $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Celsion (CLSN) United States $0.020B 0.00
Stellar Biotechnologies (EDSA) Canada $0.019B 0.00
BioCardia (BCDA) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.019B 0.00
Apricus Biosciences (SEEL) United States $0.018B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
Titan Pharmaceuticals (TTNP) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.014B 0.00
AEterna Zentaris (AEZS) United States $0.013B 0.00
Aptevo Therapeutics (APVO) United States $0.013B 0.00
ATyr Pharma (LIFE) United States $0.013B 0.00
TrovaGene (TROV) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
IMMURON (IMRN) Australia $0.007B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.006B 0.00
Spherix (AIKI) United States $0.003B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00